Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Chambers

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|May 1, 1996
Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometriumD A Fishman, K B Roberts, J T Chambers, et al.
Cancer|May 12, 1998
CA 125 may not reflect disease status in patients with uterine serous carcinomaF V Price, S K Chambers, M L Carcangiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patientsS K Chambers, C A Davis, J T Chambers, et al.
Gynecologic Oncology|December 1, 1993
Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)F V Price, S K Chambers, M L Carcangiu, et al.
Gynecologic Oncology|June 1, 1996
Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexaI Cass, E Resnik, J T Chambers, et al.
Gynecologic Oncology|August 12, 1998
Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumorK O Odunsi, L L Peck, E I Kohorn, et al.
Cancer Research|March 1, 1988
Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancersL A Cole, Y X Wang, M Elliott, et al.
Cancer|August 15, 1994
Prognostic indicators for poor risk epithelial ovarian carcinomaM Rosman, C L Hayden, R P Thiel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasmsB M Kacinski, E R Stanley, D Carter, et al.
Cancer|March 15, 1989
Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trialP E Schwartz, J T Chambers, E I Kohorn, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|May 1, 1996
Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometriumD A Fishman, K B Roberts, J T Chambers, et al.
Cancer|May 12, 1998
CA 125 may not reflect disease status in patients with uterine serous carcinomaF V Price, S K Chambers, M L Carcangiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patientsS K Chambers, C A Davis, J T Chambers, et al.
Gynecologic Oncology|December 1, 1993
Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)F V Price, S K Chambers, M L Carcangiu, et al.
Gynecologic Oncology|June 1, 1996
Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexaI Cass, E Resnik, J T Chambers, et al.
Gynecologic Oncology|August 12, 1998
Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumorK O Odunsi, L L Peck, E I Kohorn, et al.
Cancer Research|March 1, 1988
Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancersL A Cole, Y X Wang, M Elliott, et al.
Cancer|August 15, 1994
Prognostic indicators for poor risk epithelial ovarian carcinomaM Rosman, C L Hayden, R P Thiel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasmsB M Kacinski, E R Stanley, D Carter, et al.
Cancer|March 15, 1989
Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trialP E Schwartz, J T Chambers, E I Kohorn, et al.
Pageof 8